NEVVI Medicare utilization intelligence
+ Build a code basket
Medicare Texas · CY2024

Who bills the most Injection, nivolumab, 1 mg (J9299) to Medicare in Texas?

Medicare Part B FFS · CY2024 · as published by CMS
5
Billing groups
390,641
Named-group FFS services
$32,407,580
Named-group submitted charges
$83
Avg charge / service
$31
Avg allowed / service
Top-5 concentration
0%
Independent share

5 physician groups billed Injection, nivolumab, 1 mg (J9299) to Medicare fee-for-service in Texas in 2024; independent (non-hospital-affiliated) groups deliver 0%.

J9299 — Injection, nivolumab, 1 mg · Source: CMS Medicare Physician & Other Practitioners PUF (Part B), CY2024 release. Medicare fee-for-service only.

Snapshot covers the whole Texas market — the table below shows the top 100 groups (free tier).

Payer-mix context

Medicare fee-for-service covers 46% of Medicare in Texas; Medicare Advantage penetration 43% → 54% since 2020.

Market structure — concentration, independent share, and the consolidation trend for this market — is part of the market analytics platform — built, not launched yet. Notify me at launch →
#Physician groupCityStSpecialty Providers J9299 svcs Share*Phone
1 TEXAS ONCOLOGY PA DALLASTXPHYSICIAN ASSISTANT 995 251,520 51.9%
2 SOUTH TEXAS ONCOLOGY AND HEMATOLOGY, PLLC SAN ANTONIOTXHEMATOLOGY/ONCOLOGY 39 71,260 14.7% (210) 593-5700
3 AMERICAN ONCOLOGY PARTNERS PA FORT WAYNETXHEMATOLOGY/ONCOLOGY 333 46,721 9.6% (260) 484-8830
4 UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO SAN ANTONIOTXPHYSICIAN ASSISTANT 1326 11,120 2.3% (210) 450-7044
5 OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE, LLC TULSATXNURSE PRACTITIONER 47 10,020 2.1% (918) 505-3200

*Share of Texas's disclosed Medicare-FFS services for J9299, counted once per clinician. Volume is placed in the state it was billed from, so this page ranks the groups actually billing J9299 in Texas — including groups registered elsewhere ("City" is each group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group.

How to read this. Figures are Medicare fee-for-service only — not all-payer — from the CMS Medicare Physician & Other Practitioners Public Use File (Part B), CY2024 release. CMS suppresses any provider×code row under 11 beneficiaries, so a missing group means "suppressed," never zero. "Charges" are provider-submitted amounts, not payments. Groups are ranked by measured service volume attributed to clinicians in exactly one group — clinicians affiliated with several groups are listed in rosters but never volume-attributed to a single group — a direct read of the public record, not a rating or quality score. Full method: Methods & Sources.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →